news

Our latest
Press Releases & Updates

Latest press releases

Joint Initiative to Precisely Target Patient Selection for PBM Therapy in Intermediate, Dry AMD Using RetinAI’s Discovery Platform

Discover how RetinAI's groundbreaking Discovery® platform and Gutblick's clinical expertise are joining forces to transform the future of eye care. Their collaboration focuses on harnessing AI technology for advanced research and clinical applications in managing Dry Age-related Macular Degeneration. This partnership signifies a leap forward in personalized treatment and care, setting new standards in ophthalmology.

RetinAI Announces Strategic Partnership with Eyestem to Innovate Geographic Atrophy Clinical Research Using State-of-the-Art AI Technology

RetinAI and Retina Consultants of America Join Forces to build the Most Comprehensive U.S.-based Real World Evidence Database in Ophthalmology

RetinAI Medical AG and Retina Consultants of America (RCA) forge a strategic partnership to revolutionize Ophthalmology data. Leveraging RetinAI's advanced AI technologies and RCA's expansive clinic network, this alliance is set to develop the largest Real World Evidence (RWE) U.S.-based database in the field.

RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence

RetinAI Medical AG has announced a partnership with Boehringer Ingelheim to improve patient outcomes in geographic atrophy (GA). RetinAI's AI tools for identifying novel biomarkers will be used to analyze Boehringer Ingelheim's imaging datasets from clinical studies and real-world evidence to identify additional biomarkers and predictors of disease progression. This partnership aims to accelerate the development of novel treatments and enable earlier and more precise diagnosis, contributing to Boehringer Ingelheim's vision of preventing vision loss and blindness caused by retinal diseases.

Latest updates

5th international Congress OCT Angiography [DECEMBER'17]

RetinAI will be presenting the latest company's developments in this year's edition of the 5th International Congress on OCT Angiography in Rome, on the 15-16th December. Don't forget to come to our session: Unleashing the potential of longitudinal image analysis in Optical Coherence Tomography.

NVIDIA GTC Munich 2017 [OCTOBER'17]

RetinAI held a presentation during the last edition of the Nvidia GTC Europe in Munich, covering how ophthalmology is changing with Machine Learning. Stefanos Apostolopoulos (Technical Director) and Dr. Sandro De Zanet (Scientific Director) presented the efforts the company is doing to improve medical eye care around the world.

5th Medtech & Digital Health Forum Basel [OCTOBER'17]

RetinAI participated in the latest edition of the 5th Medtech & Digital Health Forum in Basel. The team had the opportunity to present our current developments and efforts towards bringing Artificial Intelligence to Ophthalmology, specially in developing countries.

Euretina 2017 + MICCAI 2017 [AUGUST'17]

RetinAI is getting ready for a September full of conferences and events! September 7-10th we will be in the 17th EURETINA Congress in Barcelona, followed by 4 days in MICCAI'2017 in Quebec. In Canada we will present our work on automatic segmentation of pathological retinal layers and participate in this year's edition of the RETOUCH challenge.

Contact us for more informations! We are happy to hear from you!